both their myeloid (M) and lymphoid (L) differentiative potentials in vitro. The modified assay involves culturing test cells at limiting dilutions on irradiated mouse marrow feeder layers for an initial 4 weeks under conditions that support myelopoiesis and then for an additional week under conditions permissive for B-lymphopoiesis. All of the clonogenic pre-B progenitors (colony-forming unit [CFU] pre-B) detected in such postswitch LTC appear to be the progeny of uncommitted cells present in the original cell suspension because exposure of lymphoid-restricted progenitors to myeloid LTC conditions for 2 7 days was found to irreversibly terminate CFU-pre-B production and, in cultures initiated with limiting numbers of input cells (no progenitors of any type detected in >70% of cultures 1 week after the switch), the presence of CFU-pre-B was tightly associated with the HE EXISTENCE IN ADULT mouse marrow of hematopoietic cells with the potential to generate both lymphoid and myeloid progeny for extended periods of time in vivo is well e~tablished."~ More recently, in vivo methods for quantitating these cells have been de~eloped.~.~ These methods have allowed significant strides to be made in their purification, characterization, and partial separation from cells with short-term in vivo repopulating ability (CFu-S),s,9 although the proportion of day 12 CFU-S that may also be long-term repopulating lymphomyeloid cells remains controversial.1°"3 In vitro methodologies for demonstrating the lymphomyeloid differentiation of single progenitor cells in highly purified populations of both fetalL4 and adultI5 murine origin have also been described recently. The latter has been useful not only for establishing the phenotype of cells in the adult that have lymphomyeloid potential, but also for identifying specific growth factor combinations that allow these differentiative potentials to be expressed.16 However, because the assay procedure involved requires the initial isolation of a highly purified population, its utility to address many questions is limited both by practical considerations and the reliance on the questionable assumption that any particular pattern of surface marker expression will be invariably associated with the defining functional (differentiative or proliferative) properties of the most primitive hematopoietic cell types. 17 An alternative approach to detecting very primitive hematopoietic cells in both unseparated and purified mouse marrow makes use of the long-term culture (LTC) system first described by Dexter et al." This culture system has been shown to reproduce many features of the environment within the marrow in vivo and to support for several weeks the maintenance and self-renewal of cells with in vivo lymphomyeloid repopulating
The frequency in adult mouse marrow of cells that form "cobblestone areas" of proliferating cells visible in the adherent layer of LTC after 4 to 5 weeks (cobblestone area-forming cells, CAFC) correlates well with the frequency of cells with in vivo long- adult mouse marrow to be 1 per 5 x lo5 cells with an enrichment of -500-fold in the Sca-l+ Lin-WGA' fraction, as was also found for competitive in vivo repopulating units (CRU) and conventionally defined LTC-IC. LTC-ICML also exhibited the same resistance to treatment in vivo with 5-fluorouracil (5-FU) as CRU and LTC-IC, thereby distinguishing these three populations from the great majority of both in vitro clonogenic cells and day 12 CFU-S. The ability to quantitate cells with dual lymphoid and myeloid differentiation potentials in vitro, without the need for their prior purification, should facilitate studies of totipotent hematopoietic stem cell regulation.
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term repopulating ability (LTRA), both before and after their extensive purification." In addition, some cultures with cobblestone areas also contain cells that can reconstitute lymphoid and myeloid lineages on their transplantation into irradiated recipient mice." Thus CAFC and in vivo repopulating cells have been considered to be overlapping, if not identical, populations. Direct examination of the lymphopoietic potential of murine CAFC has been precluded by the fact that the conditions used for their detection are not permissive for lymphopoiesi~.~~ However, it has previously been shown that B-lymphoid cell development may be observed when established LTC are "switched" to conditions originally described by Whitlock and Wittez4 that do support the long-term in vitro production of murine B-lineage ~e l l s .~~~~ We now show that extension of the conventional limiting dilution CAFC assay with a l-week culture period under Whitlock-Witte conditions after an initial 4 weeks under standard myeloid conditions and the use of both a myeloid and a pre-B clonogenic cell readout allows the quantitation in vitro of a subpopulation of LTC-initiating cells (LTC-IC) that have demonstrable myeloid and lymphoid potential (LTC-ICML). These cells also share other distinguishing properties of long-term in vivo repopulating cells. The LTC-ICML assay is applicable to unseparated, as well as highly purified starting populations, and should, therefore, complement and extend existing methodologies for investigating the molecular basis and control of hematopoietic stem cell self-renewal and lineage determination.
MATERIALS AND METHODS

Animals.
Eight-to 16-week-old (CS7BL/6J X C3H/HeJ)FI (B6C3Fl) and (CS7BL/6 Pep3b X C3H/HeJ)FI (PepC3FI) mice bred and maintained in the animal facility of the British Columbia Cancer Research Centre (Vancouver, British Columbia, Canada) were used in all experiments. Parental strain breeders were originally obtained from the Jackson Laboratories (Bar Harbor, ME). B6C3Fl mice are homozygous for the Ly-5.2 allele. PepC3FI are Ly-S.I/Ly-5.2 heterozygotes.
Prepurution of murrow cell suspensions. A 2 I -gauge needle was used to flush marrow cells from femurs and tibias into cold Alpha medium containing 2% fetal calf serum (FCS) (Stemcell Technologies Inc [.ST[], Vancouver, British Columbia). Single-cell suspensions were then obtained by repeated gentle aspiration through the needle. For studies of in vivo effects of S-fluorouracil (S-FU), mice were injected intravenously (IV) with IS0 mgkg body weight of sterile S-FU (Hoffman La Roche, Basel, Switzerland) 2 days before harvesting the marrow. For antibody labeling experiments, cells were collected in ice-cold Hank's balanced salt solution (STI) containing 2% FCS (HF), incubated for 30 minutes on ice in ammonium chloride to lyse red blood cells, centrifuged, and gently resuspended in HF.
Cell purijcarion. Antibodies and reagents for immunologic staining were obtained and used as previously described in detail." Briefly, PepC3FI marrow cells were incubated for 30 minutes with the following fluorescein isothiocyanate (F1TC)-labeled lineage-specific (Lin) antibodies: antiLB220, anti-Ly-l, anti-Gr-l, and anti-Mac-I, After two washes with HF to remove unbound antibody, the cells were incubated for 2. 5 minutes with BioMag sheep antifluorescein IgG magnetic beads (Advanced Magnetics, Cambridge, MA) and Lin' cells depleted by magnetic separation according to the manufacturer's directions. After two more washes with HF, the cells were incubated for 30 minutes with biotinylated wheat-germ agglutinin (WGA) and again washed twice. The cells were then stained with an antibody cocktail containing the same FITC-labeled anti-Lin antibodies as before, anti-Sca-I labeled with cyanine S succinimidyl ester (Cy-S), and streptavidin-conjugated phycoerythrin (SA-PE). The cells were then washed two tinal times, with propidium iodide (PI) added to the last wash to allow the detection of nonviable cells. An aliquot of stained but unsorted cells was set aside for use in the determination of enrichment and recovery values. Cells were sorted on a FACStar' (Becton Dickinson CO, San Jose, CA) equipped with 5 W argon and 30 mW helium neon lasers. Viable (PI-negative) cells were gated to retain the population of Sca-l ' cells with low forward and orthogonal light scattering properties. From this population, the Lin-WGA+ fraction was collected under sterile conditions into SO% HF. Use of the same controls and gate settings as previously described" allowed the reproducible isolation of the 0.02% of total nucleated PepC3FI marrow cells that have a Sca-1 +Lin-WGAC phenotype ( Table l ) .
In vivo assuy j o r colony-jbrming units-spleen (CFU-S). The day 12 CFU-S content of cell suspensions was determined as originally described." Briefly, 4 to 8 X IO4 normal marrow cells or S to 8 X 10' marrow cells from S-FU treated mice were injected into syngeneic recipients that had been irradiated with 950 cGy given in a single dose from a "'CS y-ray source (Atomic Energy of Canada. Chalk River, Ontario, Canada). The spleens were excised I2 days later and fixed in Telleyesniczky's solution. and macroscopic surface colonies were counted I n r . i t~~ cissuy jor competitive repopuluting units (CKU). A moditication of the limiting dilution assay for CRU described by Szilvassy PepCSF, origin were injected together with I o ' unseparated fresh adult marrow cells from B6C3F, mice into B6C3FI recipients that had been irradiated with 950 cCy (as for CFU-S assays). After 2 5 weeks, a small blood sample was taken from the tail of each recipient and the nucleated cells then stained with FITC-labeled anti-Ly-S. I and biotinylated anti-Gr-l plus SA-PE. FCS, I c/o bovine serum albumin, 0.1 mmol/L 0-mercaptoethanol (p-ME), 3 U/mL human erythropoietin, and 2 8 pokeweed mitogenstimulated mouse spleen cell conditioned medium (STI), and I mL aliquots plated in 3. 5 mm petri dishes (STI). Colonies were scored in situ after 14 days of incubation at 37°C in a humiditied atmosphere of 5% COz in air, using criteria established and used in this laboratory for many years.'" A modification of a previously described CFUpre-B assay was used to detect clonogenic pre-B cell progenitors." Briefly, cells were plated in I mL cultures of Alpha medium containing 0.8% methylcellulose, 30% of a selected batch of FCS. 0 . I mmol/L &ME (STI) plus 0.2 ng/mL recombinant human interleukin-7 (1L-7; Immunex, Seattle, WA) and, for cultured cells, 5 ng/mL recombinant murine Steel factor (SF; Immunex). The predominant colony type arising from fresh marrow cells plated in IL-7 alone for 7 days at 37°C in 5 6 CO2 in air possessed the distinctive morphology of B-lymphoid colonies" '' and >90% of the cells from individually analyzed colonies were 8220; by fluorescence-activated cell sortcr (FACS). In contrast, cells harvested from "switched" long-term cultures (see below) frequently gave rise to some monocytic and granulocytic colonies when the CFU-pre-B assays contained SF as well as IL-7. In addition. there were other colonies produced in these assays that did not have a typical pre-B colony morphology. but were found to contain 8220' cells by FACS analysis, or cells with a typical lymphoid morphology on staining with May-GriinwaldGiemsa. These colonies often contained two distinct B220' populations, one much brighter than the other, possibly indicating a mixture of pro-(8220' ) and pre-B (8220") cells. Whenever it was difticult to make a lineage assignment based solely on colony morphology, the colonies were individually plucked and either stained with MayGrunwald-Giemsa for morphologic analysis or pooled by colony type for analysis of B220 expression by FACS. Preliminary experiments contirmed"." that the number of CFU-pre-B detected in fresh marrow i n the presence of IL-7 alone or in cultured cell preparations in the presence of SF plus 1L-7 was a linear function of the input cell concentration (data not shown).
In l i f r o m w y j b r LTC-IC. Test cells were cultured in Alpha medium supplemented with 12.5% FCS, 12.5% horse herun), 0 . I 
Values shown represent the mean t-SEM from (n) experiments. Recovery and enrichment values were calculated from experiments where the same cells were assessed both before and after their purification.
by seeding the test cells onto irradiated ( I ,500 cGy). adherent marrow feeder layers established IO to 14 days earlier i n the same medium from an inoculum o f I to 1.5 X IO" normal mouse marrow cells per cm' o f tissue culture surface. The cultures were then maintained at 33°C with weekly half medium changes and concomitant removal of half of the nonadherent cells. After 4 weeks. each culture was harvested separately, corresponding adherent and nonadherent fractions pooled. and then each combined suspension assayed for BFU-E, CFU-GM, and CFU-GEMM. Using the same statistical methods as for calculating CRU frequencies. the frequency of LTC-IC in the test population was determined from the proportion of negative cultures (ie, those containing none o f these myeloid clonogenic cells) at each input cell dose tested. for a funher week. At the end o f this time, each culture was harvested individually, trypsinized adherent cells pooled with their corresponding nonadherent cclls. and half of the combined cells werc assayed for myeloid clonogenic cells (BFU-E, CFU-GM. and CFU-GEMM) and the other half for CFU-pre-B. LTC-IC,,, frequencies in the original test cell suspension were calculated as described above for CRU and LTC-IC from the proportion o f negative cultures (dctined in this case as thosc that did not contain both myeloid and lymphoid clonogenic cells) at each input cell dose tested. Table I shows a comparison of the frequency and phenotype of LTC-IC (as defined here using a 4-week myeloid clonogenic cell output end point) with various other progenitor cell types detectable in normal adult mouse marrow. including CRU. The frequencies of LTC-IC and CRU were calculated by limiting dilution analysis as described in Materials and Methods. As can be seen, the frequency (and hence the number) of CRU in normal marrow was found to be the same as that measured previously5~" and is approximately twice that of LTC-IC, but only approximately '/,,,,th that of either the pre-B lymphoid or total myeloid clonogenic progenitors detectable in vitro. In addition, the small subpopulation of Sca-I'Lin-WGA' cells in normal adult mouse marrow that was previously shown to be highly enriched in CRU".'' was found to be enriched to the same extent (approximately 700-fold) in LTC-IC and with a similar recovery, with simultaneous elimination of most (>90%) of the in vitro clonogenic Table 2 shows a comparison of the effect of 5-FU (150 mgkg body weight) given in vivo on the marrow content of CRU and LTC-IC 2 days later. In this case, frequency measurements were multiplied by the total femoral cellularity to obtain the absolute population size estimates shown. CRU and LTC-IC populations both showed slight (three-to fourfold) decreases after 5-FU treatment. In contrast, parallel measurements of the number of in vitro clonogenic myeloid and pre-B progenitors as well as day 12 CFU-S in the same marrow cell suspensions showed these populations to be markedly reduced (280-fold), as previously r e p~r t e d .~"~~ Thus, by several parameters (frequency, surface antigen expression, and sensitivity to 5-FU in vivo), LTC-IC defined by a 4-week myeloid clonogenic cell end point were indistinguishable from CRU and both were separable from the majority of cells detectable by short-term colony assays, including day 12 CFU-S. Data from these studies were also used to analyze the relationship between the number of cells seeded into LTC-IC assay cultures and the average myeloid clonogenic cell output measured 4 weeks later. As shown in Fig 2, the clonogenic cell content of 4-week-old myeloid LTC was found to be directly proportional to the input cell number over a wide range of values. The slope of the lines fitted to the data did not significantly differ from linearity in LTC-IC assays of unseparated marrow from normal (P = .59) or 5-FU treated ( P = .48) mice or for those initiated with very low numbers (25 to 100) of Sca-l+Lin-WGA' cells ( P = .36). These results validate the use of graded doses of input marrow cells and limiting dilution analysis to quantitate the LTC-IC content of both unseparated marrow cells suspensions and derivative fractions that may be variably enriched in their LTC-IC content.
RESULTS
Sirnilorities of LTC-IC NIKI CRU.
Development of an assay for lymphomyeloid LTC-IC (LTC-IC,,) . The LTC-IC assay described above clearly provides a means of quantitating a population of primitive cells that share a number of features of cells with in vivo lymphomyeloid differentiation potential. Nevertheless, the culture conditions used do not allow detection of the lymphoid potential that some LTC-IC might be expected to possess. To overcome this limitation, we took advantage of the observation that when murine myeloid LTC are "switched" to conditions that are permissive for B-lymphopoiesis, production of B-lineage cells can sometimes be initiated.25. 26 We hypothesized that if cultures were switched after an initial 4-week period under myeloid LTC conditions (in order that all myeloid clonogenic cells detected could be assumed to have arisen from LTC-IC), it might be possible to identify a time when the production of Cm-pre-B was well under way before the production of myeloid clonogenic cells had markedly decreased. To investigate this possibility, we measured the rate of appearance of CFU-pre-B and the concomitant disappearance of myeloid progenitors in LTC-IC assay cultures that, instead of being harvested at 4 weeks, were switched to Whitlock-Witte conditions (different medium, 37°C) for variable periods of time, and then harvested and assayed as described in Materials and Methods. Figure  3 shows the combined results of three such experiments. As expected, no CFU-pre-B were present at the time of the switch in any experiment (ie, after 4 weeks under myeloid LTC conditions) or for the first 4 days thereafter. Within 7 days, however, CFU-pre-B had become readily detectable and over the course of the next 7 days, their numbers continued to increase rapidly before leveling off. Concomitantly, the initially large number of myeloid clonogenic cells present in 4-week-old myeloid LTC declined progressively to < 1% of the input number (<0.1% of the number present at the time of the switch) by the third week postswitch. Based on the initial findings from these experiments, subsequent studies focused on an analysis of cultures harvested 1 week after the switch (ie, 5 weeks after their initiation, shown schematically in Fig 1) at a time when CFU-pre-B, although not yet present at maximal levels, are nevertheless readily detectable.
Validation of the LTC-ICML assay. To evaluate the usefulness of the LTC-ICML assay as a method for quantitating cells in variously manipulated test cell suspensions, the relationship between the number of cells initially seeded into each assay culture and the number of clonogenic myeloid and lymphoid cells detectable 5 weeks later was assessed. As shown in Fig 4, the output of CFU-pre-B increased linearly with increasing input cell concentrations (P = 9 1 ) .
As expected from Fig 2, the number of myeloid clonogenic cells measured simultaneously also increased as a function of the input cell number (data not shown). However, the 1343 majority of these would have been derived from myeloidrestricted LTC-IC (see below) and, hence, a meaningful assessment of the relationship between input cell dose and output of LTC-ICML-derived myeloid clonogenic cells could not be made.
Use of the design shown in Fig 1, even as a limiting dilution procedure, to detect an input cell with dual lymphoid and myeloid potential assumes that none of the CFU-pre-B detected 1 week after switching culture conditions would be derived from a lymphoid-restricted progenitor present at the initiation of the culture. The consistent absence of CFUpre-B in 4-week-old cultures at the time of the switch (Fig  3) provides some support for this assumption. However, it would not exclude the potential persistence of a corticosteroidhorse serum-resistant, lymphoid-restricted CFU-pre-B progenitor. To address such a possibility, three additional types of analyses were undertaken. In the first, the distribution of CFU-pre-B and myeloid clonogenic cells was examined in cultures initiated with limiting numbers of input cells. For this analysis, we evaluated only those cultures where the input was such that 530% of the cultures assessed at the end of the 5-week period were found to contain any type of clonogenic cell (either lymphoid or myeloid). In such cases, it is unlikely ( P < ,15) that more than one cell with the capacity to generate either lymphoid or myeloid clonogenic progeny detectable 5 weeks later would have been seeded into a single culture. Eleven of the 98 such cultures analyzed (Table 3) contained CFU-pre-B. In 10 of these, myeloid clonogenic cells were also present, ie, significantly more often than the two (of 11) expected, if the presence of myeloid clonogenic cells and CFU-pre-B in the same culture were due to the coincident input of two independently segre- For * Because LTC-IC are more frequent than LTC-ICML, only input numbers such that 530% of LTC contained any type of clonogenic cell after 5 weeks were considered in this analysis as <15% of such cultures are expected to contain more than one responding cell.
gating progenitor cell types occurring at the observed frequencies of myeloid-positive (22%) and lymphoid-positive cultures (11%) (P < ,0001, Fisher's Exact Test). These I 1 cultures were also useful for defining the variability in clonogenic cell output characteristic of individual LTC-ICMI,. The number of CFU-pre-B present among the 5-week progeny of single LTC-ICML ranged from two to 146 (median, 55) and the corresponding number of myeloid clonogenic cell progeny ranged from three to 138 (median, 9). The latter were comprised mainly of CFU-M and CFU-GM, but in one of the 1 I cultures, included six CFU-GEMM.
The second approach we used to investigate the single cell origin of mixed lymphoid-myeloid cultures in the LTC-ICML assay was to evaluate the distribution of progenitor types in cultures initiated with subpopulations of normal mouse marrow. The Sca-l-fraction was found to be depleted of LTC-ICMi--5-fold, and these cells enriched -40-fold in the Sca-l+ fraction. Further selection of the rare (-0.02% of total bone marrow) Sca-l+Lin-WGA+ subfraction did not allow the lymphoid and myeloid clonogenic cell-producing activities of whole marrow to be separated and both types of progenitors could be found together in cultures initiated with as few as 35 Sca-I+Lin-WGA+ cells. As shown in Table I , this fraction was found to be enriched to a similar extent (approximately 5W-fold) for LTC-ICML, as for CRU and LTC-IC, and with approximately the same overall recovery (7%).
A third set of experiments was performed to address the possibility that there might exist a very early (pre-CFUpre-B) but lymphoid-restricted progenitor that could persist throughout the initial 4 weeks of myeloid LTC, but not yield detectable progeny CFU-pre-B until after the switch to conditions permissive for their survival. The possible existence of such a cell has been inferred from the finding that cells from 6-to 20-week-old lymphoid LTC can on adoptive transfer into immunocompromised mice reconstitute and sustain polyclonal B-and T-lymphopoiesis for up to 10 to 12 even though neither CFU-S nor marrow repopulating cells could be detected after 6 weeks in lymphoid LTC4' (see also Fig 3) . We, therefore, initiated a series of cultures with normal marrow and maintained them for 8 weeks at 37°C as described by Whitlock and Witte.14 At the end of this initial culture period, duplicate cultures were harvested and their CFU-pre-B content measured (Table 4) . Half of the remaining flasks were then switched to myeloid LTC conditions by removing and discarding all of the culture medium and nonadherent cells, washing the adherent layer twice with warm RPMI, replacing the original volume with myeloid LTC medium, and incubating the cultures at 33°C. The remaining flasks were mock switched by performing the same manipulations, but replacing the original volume of lymphoid LTC medium with an equal amount of fresh lymphoid LTC medium and returning the cultures to 37°C. After a further 7 days, all of the cultures were switched to (or continued in) lymphoid LTC conditions and then maintained for a final 4 weeks without further change. All cultures were then harvested and assayed individually for CFU-pre-B. As shown in Table 4 , production of CFU-pre-B could not be reinitiated in lymphoid cultures that had been exposed to myeloid LTC conditions for 7 days despite the continued output of CFU-pre-B in control LTC maintained uninterrupted under lymphoid conditions, suggesting that myeloid LTC conditions are highly and rapidly toxic to the earliest reported lymphoid progenitor types.
Sensitivity of LTC-IC,, to 5-FU in vivo. Given the differential effect of a single injection of 150 mgkg body weight of 5-FU on CRU and LTC-IC populations (resistant) as compared with CFU-S and in vitro clonogenic pre-B and myeloid progenitors (highly sensitive), it was of interest to examine the same cell suspensions for the effect of this treatment on LTC-ICML. Accordingly, as for the other types For personal use only. on March 31, 2017 . by guest www.bloodjournal.org From of progenitors measured, LTC-ICML numbers were determined by limiting dilution analysis and population sizes calculated before and after 5-FU treatment. The results are presented in Table 2 . It can be seen that the 5-FU treatment reduced the femoral content of LTC-ICML to approximately the same extent (threefold) as measured for both CRU and LTC-IC, and in marked contrast to the dramatic reduction (280-fold) observed for both myeloid-and lymphoid-restricted progenitors detected in short-term in vitro clonogenic assays as well as for day 12 CFU-S.
DISCUSSION
Much attention is currently focused on the identification and characterization of molecular events that bring about changes in the totipotency of hematopoietic stem cells, including those that remain functionally intact throughout normal adult life. Such studies require biologic assays that permit the full differentiative potential of these cells to be displayed and also allow their discrimination from progeny with more restricted properties. The approach that appears to satisfy these requirements best involves the transplantation of test cells into a congenic host that has been sufficiently perturbed hematologically to provide a suitable environment for any injected hematopoietic stem cell to generate identifiable progeny belonging to all of the various hematopoietic lineage^.','^.^^.^^ While this approach has been useful in establishing that many CFU-S are not totipotent long-term repopulating cells,' it does not easily lend itself to investigations of the stage at which any particular differentiative function of a manipulated or altered stem cell may become manifest. Moreover, the extent and nature of the stimulation provided by the microenvironment of the injected mouse is difficult to assess (or modify).
An alternative approach would be to try to define in vitro conditions and end points that allow the specific detection of totipotent hematopoietic cells. Recently, conditions have been described for the in vitro detection of murine cells with B-lymphoid, as well as varying degrees of myeloid differentiation potential. However, the applicability of these procedures is restricted to either fetal test cells14 or highly purified adult marrow p0pu1ations.l~ In this report, we have shown how the principles of the LTC-IC assay, previously developed for both human4 and murine" myeloid progenitors, can be used to overcome the inherent limitations of all of the approaches reported to date. First, the LTC-ICML assay procedure we have described is performed entirely in vitro. Second, it is both quantitative and specific for cells with lymphomyeloid differentiation potential. Finally, it can be applied to unseparated, as well as highly purified, populations of adult mouse bone marrow.
Several lines of investigation were pursued to establish the specificity of the LTC-ICML assay as previous work by Dorshkindzs and Denis and Witte26 (on which the LTC-IC,, assay is based) had not excluded the important possibility that a lymphoid-restricted progenitor might persist under Dexter culture conditions and then subsequently generate CFU-pre-B when the cultures were switched to more permissive conditions for this latter cell type. Analysis of the clonogenic cell content of LTC-ICML assay cultures initiated with S 1 clonogenic precursor per culture (P > .85) showed that the presence of CFU-pre-B and myeloid clonogenic cells 5 weeks later were not independent events ( P > .9999).
Second, even in highly purified cell suspensions, cells able to produce CFU-pre-B in the LTC-ICML assay could not be separated from cells able to generate myeloid progeny. Third, although cells from lymphoid cultures have previously been shown to reconstitute polyclonal B-lymphopoiesis, but not myelopoiesis, on adoptive transfer into immunodeficient
we were unable to demonstrate the persistence of either CFU-pre-B or their putative lymphoidrestricted precursors after a single week of exposure to myeloid LTC conditions. Taken together, these results provide strong evidence that the LTC-ICML assay detects individual cells with lymphomyeloid potential.
Some differences were found, however, in the frequencies of cells detected as CRU, LTC-IC, and LTC-ICML (particularly the latter). One possible explanation for these discrepancies is that each assay detects a distinct population. Another possibility is that the end point used in each case measures biologically identical or highly overlapping populations, but with different efficiencies. The 4-day lag time that we observed before the appearance of CFU-pre-B in postswitch LTC-ICML assay cultures (Fig 3) and the failure to detect the persistence of any earlier type of B-lineage restricted precursor (Table 4) suggests that the CFU-pre-B detected in postswitch cultures may have to differentiate from those LTC-ICML still present after a 4-week period of culture under myeloid culture conditions. Previous studies have shown that CRU decline approximately sevenfold during that time." Thus, the design of the LTC-IC,, assay may include a corresponding inherent decrease in plating efficiency.
We have also demonstrated that the myeloid clonogenic progenitor output of the LTC-IC assay and the CFU-pre-B output of the LTC-ICML assay are linearly related to the concentration of LTC-IC and LTC-ICML, respectively, in the starting cell suspension. Moreover, this was true for a wide range of input cell numbers, both for unseparated and highly purified test cell populations although, not surprisingly, some inhibition was apparent at the highest starting cell concentrations. Such a linear input-output relationship validates the use of limiting dilution statistics to derive absolute frequencies of the cell type being assayed, as long as excessive input cell concentrations are avoided.
In the present study, we exploited this fact to carry out a comparison of the numbers and properties of cells defined generically as LTC-IC (4-week myeloid end point) and specifically as LTC-ICML (5-week myeloid plus lymphoid end point), and CRU (cells capable of reconstituting and sustaining long-term lymphomyelopoiesis in vivo). All three methods were found to detect cells with the same rare surface antigen phenotype and high resistance to in vivo administration of 5-W, the latter presumably reflecting a similarly slow rate of turnover of these cells in the normal adult mouse. Importantly, these characteristics of LTC-IC, LTC-ICML, and CRU were not shared by the majority (>90%) of progenitors detectable in short-term clonogenic assays, including day 12 CFU-S (Table 2) . While it has been clear for some time that
For personal use only. on March 31, 2017 . by guest www.bloodjournal.org From not all day 12 CFU-S are detectable as CRU,'" the data in Table 2 provide the first quantitative evidence that some CRU and LTC-IC are not likely to be detectable as day 12 CFU-S, because 2 days after in vivo exposure of mice to 5-W, the number of day 12 CFU-S present in the femur was <20% of the number of CRU or LTC-IC.
In summary, we have devised a new in vitro method for identifying and quantitating lymphomyeloid cells (LTC-ICML) in adult mouse bone marrow which relies on the joint expression of these differentiative potentials in the same culture. The molecular signals responsible for stimulating the various differentiation events that LTC-ICML must undergo to be detected remain undefined although, based on what has been learned for human LTC-lC45 and murine and human CAFC,"6.47 we presume that these cells are activated by factors produced by fibroblasts in the irradiated adherent marrow feeder layers. Both LTC-IC and LTC-ICML appear to be closely related to totipotent murine cells with longterm in vivo repopulating potential (CRU). The LTC-IC and LTC-ICML assays may, therefore, serve as useful surrogate procedures for investigating factors that affect CRU function and maintenance in culture. The present studies also support the likelihood that the human LTC-IC assay may detect cells with similar properties including long-term in vivo repopulating potential.
